University of California San Francisco
Give to UCSFUCSF has signed an alliance with international pharmaceutical company Sanofi to share expertise in diabetes research and identify drug targets that could lead to new therapies for both type 1 and type 2 diabetes.
A group of scientists at UCSF and Columbia University estimates that slapping a penny-per-ounce tax on sweetened beverages would prevent nearly 100,000 cases of heart disease, 8,000 strokes and 26,000 deaths every year.
<p>In a study published online in the <em>Journal of Obesity</em>, mastering simple mindful eating and stress-reduction techniques helped prevent weight gain without dieting.</p>
A new interactive mobile phone app called DiabetesIQ challenges people to test their knowledge of diabetes and to compete with one another as they learn about the complexities of the disease.
A survey of federally funded diabetes prevention and control programs in 57 U.S. states and territories has highlighted the need for better diabetes treatment guidelines that are specifically adapted to different populations. Such guidelines do not currently exist.
A somewhat mysterious soft tissue found in the fetus during early development in the womb plays a pivotal role in the formation of mature beta cells the sole source of the body’s insulin. This discovery, made by scientists at University of California, San Francisco (UCSF) and Texas A&M University, may lead to new ways of addressing Type 1 and Type 2 diabetes.
<p>The UCSF Diabetes Family Fund for Innovative Patient Care, Education and Scientific Discovery, created by one anonymous donor who is committed to diabetes research, is financing 11 projects that support creative, collaborative and imaginative innovations in diabetes clinical care, patient education, medical training and clinical and basic research. </p>
<p>Experts at UCSF and Caltech are pushing the boundaries of creative problem solving to address important clinical problems with the hope that the talent pool at both institutions, combined with an entrepreneurial spirit, will advance health care innovation.</p>
Scientists at the UCSF Cardiovascular Research Institute have discovered how a change in growth hormone activity in mice leads to fatty liver disease, a condition whose human counterpart is of rising concern worldwide.
A multinational study has identified a key gene mutation responsible for type 2 diabetes, a finding that could lead to developing a predictive test for the disease, identifying which current medications work best and driving pharmaceutical research to find new therapies.
Among those cheering the recent opening of the new stem cell science building at UCSF were two patient advocates who have a personal connection to advancing the field of regenerative medicine.
UCSF pediatric endocrinologist Steve Gitelman leads type 1 diabetes clinical trials with the goal of halting beta cell destruction and thereby stopping the progression of disease soon after it is diagnosed.
Leading scientists from California companies discussed groundbreaking clinical trials of stem cell therapies during a recent scientific symposium to celebrate the opening of the Ray and Dagmar Dolby Regeneration Medicine Building at UCSF.
People with limited education and in certain racial/ ethnic minority groups are less likely to use an internet- based patient portal to interact with their health care system, according to a new study from researchers at the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, CA.
Carmen Peralta, assistant professor of medicine, was recognized recently for her outstanding work in the field of racial and ethnic differences in kidney disease detection, progression and complications.
Carmen A. Peralta, MD, assistant professor of medicine in the Division of Nephrology at the UCSF School of Medicine, was recognized recently with a 2010 Nickens Faculty Fellowship.
Cutting back on salt in teenagers’ diets by as little as one-half teaspoon, or three grams, a day, could reduce the number of young adults with high blood pressure by 44 to 63 percent, according to new research presented Sunday, Nov. 14 at the American Heart Association’s Scientific Sessions 2010 meeting in Chicago.
New technologies and techniques continue to accelerate the pace of discovery in human genetics research, a fact made clear by scientists who spoke about their searches for important mutations, gene variants and answers to basic biological questions at the UCSF Institute for Human Genetics’ fifth-anniversary symposium on Oct. 28.